Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 9/20 | 0.80 |
| ▸ | CA9 | Q16790 | 9/20 | 0.80 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 6/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22331103 | 0.88 | NPSR1 (0.86) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL23928616 | 0.87 | MAPT (0.77) | CA12CA9MAPK1MAPTCA1 | |
| SCHEMBL7965075 | 0.85 | NPSR1 (0.77) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL23928668 | 0.85 | CA12 (0.80) | CA12CA9MAPTCA1CA2 | |
| SCHEMBL23928475 | 0.83 | MAPT (0.73) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL14133024 | 0.82 | NPSR1 (0.76) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL14133285 | 0.81 | NPSR1 (0.74) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL22331098 | 0.81 | NPSR1 (0.73) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL14133580 | 0.80 | CA12 (0.74) | CA12CA9NPSR1MAPK1NPC1 | |
| SCHEMBL12932082 | 0.79 | KMT2A (0.80) | CA12CA9NPSR1MAPK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11548875-B2 | Inhibitor compounds for male contraception | UNIVERSITY OF WASHINGTON (US) | 2023-01-10 | — | — | US | disclosed |
| US-20210332030-A1 | INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION | UNIVERSITY OF WASHINGTON (US) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332030-A1 | INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION | ALDH1A1, ALDH3A1, ALDH16A1 | CA12 4702/4885CA9 4751/4885NPSR1 3150/4885 |
| US-11548875-B2 | Inhibitor compounds for male contraception | ALDH1A1, ALDH3A1, ALDH16A1 | CA12 4702/4885CA9 4751/4885NPSR1 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.